Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sanofi Consumer Healthcare India appoints PwC as statutory auditor for five-year term - scanx.trade
Sanofi Consumer Healthcare India appoints PwC as statutory auditor for five-year termscanx.trade
Gainers & Losers: LIC, Max Healthcare among 7 big movers on Monday
Domestic equity markets extended gains for a third straight session. LIC, Vodafone Idea, Eicher Motors and Titagarh Rail Systems surged, while JSW Cement and Max Healthcare declined.
Schroders Capital plans to build on $1 bn India investment as scope for early investor exits grows beyond IPOs
The company is scouting for opportunities in sectors including consumer, healthcare, technology and artificial intelligence.
Board of Blue Jet Healthcare approves fund raising up to Rs 1,000 cr via equity route
At meeting held on 25 May 2026
Blue Jet Healthcare standalone net profit declines 41.56% in the March 2026 quarter
Sales decline 31.07% to Rs 234.67 crore
Blue Jet Healthcare Q4 Results: Stock gains 10% despite weak earnings; Board approves fund raise
For the March quarter, Blue Jet Healthcare's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) fell 49% to ₹71 crore from ₹140 crore a year ago, while EBITDA margin contracted sharply to 30.3% from 41%. Yet, the stock was up 10%.
80% return in six months! Healthcare stock Park Medi World hits record high after this acquisition update
Park Medi World share price has gained 20% in one month and has jumped 48% in three months. The stock has surged 86% on a year-to-date (YTD) basis.
Six pharma stocks that should be on your radar today over various news triggers
It was a busy weekend for pharma stocks as four of them — Divi's Laboratories, Fortis Healthcare, Torrent Pharma and Narayana Hrudayalaya — reported their quarterly results. Meanwhile, Lupin marked its entry into the Chinese market, while Glenmark Pharma's US arm settled an anti-trust litigation. Here's a look at these names in detail:
Ahead of Market: 10 things that will decide stock market action on Monday
Indian equity benchmarks closed modestly higher on Friday, with financial stocks leading the gains. The Nifty and Sensex edged up, though pharma and healthcare weakness capped the rise. Analysts noted the market's indecisive range-bound movement, awaiting a decisive breakout above 23,800 for further upward momentum or a fall towards 23,600.
6 pharma stocks that Bernstein sees up to 40% upside potential. Do you own any?
Bernstein initiated coverage on six pharma stocks, expressing a positive outlook on the Indian healthcare sector driven by AI, innovation in niche areas, and a strengthening ecosystem. The brokerage highlighted attractive valuations and easing policy uncertainties, naming Zydus Lifesciences as its top pick with a significant upside potential.
Sakar Healthcare partners with Zydus Lifesciences for GCC Markets
Sakar Healthcare has partnered with Zydus Lifesciences to supply oncology products in GCC countries and other emerging markets. This marks the company's 40th global agreement in the anti-cancer segment. Sakar Healthcare is expanding its international oncology business and strengthening its presence in emerging markets. The company is also progressing with regulatory filings and approvals in highly regulated markets.
Kerala’s healthcare gold rush: How private equity is reshaping hospitals and raising fears over costs
Private equity funds are pouring hundreds of millions of dollars into Kerala’s healthcare sector, reshaping a system long dominated by independent doctors and family-run hospitals.